Archive | Burundi

RSS feed for this section

Defeating malaria through pharmaceutical systems strengthening

SIAPS has received funding from the US President’s Malaria Initiative (PMI) to work in eight countries—Angola, Burundi, Democratic Republic of the Congo (DRC), Ethiopia, Kenya, Guinea, Mali, and South Sudan—to strengthen pharmaceutical systems for improved malaria control. This report synthesizes the pharmaceutical systems strengthening efforts of SIAPS and documents how the approach was used to support efforts to control malaria.

Read full story · Comments are closed

Defeating malaria through pharmaceutical systems strengthening: A review of SIAPS’s activities in eight countries

SIAPS recently published the results of its activities in eight countries (Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Kenya, Guinea, Mali, and South Sudan) to control malaria. This report summarizes systems strengthening interventions that support the prevention and treatment of malaria. With funding from the US President’s Malaria Initiative (PMI) and based […]

Read full story · Comments { 0 }

Technical Highlight: Design, Implementation, and Use of Pharmaceutical Logistics Management Information Systems (LMIS)

This technical highlight describes promising practices in assessing, designing, and implementing a LMIS based on SIAPS Program’s experience. The promising practices are supported by case examples of LMIS implementation from Bangladesh, Swaziland, and West Africa.

Read full story · Comments are closed

Systems for Improved Access to Pharmaceuticals and Services: Malaria Quarterly Update – January—March 2016

Working closely with the President’s Malaria Initiative (PMI) in both Washington and PMI- focus countries, the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program aims to ensure the availability of quality pharmaceutical products and effective pharmaceutical services in support of PMI objectives. To this end, and based on the PMI’s priorities, SIAPS endeavors to improve pharmaceutical governance, build capacity to manage malaria products while addressing the information needed for managing them, strengthen financing strategies and mechanisms to improve access to malaria medicines, and improve the quality of pharmaceutical services provided to malaria patients.

The SIAPS technical approach emphasizes health systems strengthening with a special focus on improving metrics, monitoring and evaluation (M&E), developing the capacity of local governments and organizations, and increasing country ownership. Through this approach, SIAPS aims to promote the availability and use of malaria products, including artemisinin-based combination therapy (ACT), rapid diagnostic tests (RDT), and medicines for severe malaria. At the country level, SIAPS collaborates with national malaria control programs and Central Medical Stores (CMS) to develop and implement strategies to strengthen pharmaceutical management to prevent and improve case management of malaria. Areas supported by SIAPS include: training; quantification; strengthening supply chain systems, including logistics management information; community and malaria case management; rational use; and medication safety. SIAPS works to strengthen malaria pharmaceutical management at the national level in Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Guinea, Mali, Niger, and South Sudan. In addition, SIAPS provides regional support in Latin America.

This report describes the major activities that SIAPS conducted at the global level and in each of the countries and region mentioned above between January and March 2016.

Read full story · Comments are closed

Ensuring Access to and Appropriate Use of Medicines for iCCM: It takes a system

Briggs J, Joshi MP, Yeager B, Diarra S. Ensuring access to and appropriate use of medicines for iCCM: It takes a system. Oral presentation at the 143rd American Public Health Association (APHA) Annual Meeting and Expo, Chicago, IL, USA. November 3, 2015.

 

Read full story · Comments are closed

Malaria PMI Quarterly Updates April-June 2015

According to the World Health Organization (WHO), 1 malaria mortality rates fell by 47% globally, and by 54% in Africa between 2000 and 2013. During this period, an estimated 4.3 million malaria deaths were averted globally, primarily as a result of the scale-up of interventions. However, much remains to be done. Although 55 countries are on track to reduce their malaria case incidence rates by 75%, in line with the World Health Assembly and Roll Back Malaria (RBM) targets for 2015, these countries account for only 3% of all malaria cases.

Working closely with the President’s Malaria Initiative (PMI) in both Washington and PMI focus countries, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program aims to ensure the availability of quality pharmaceutical products and effective pharmaceutical services in support of PMI objectives. To this end, and based on the PMI’s priorities, SIAPS endeavors to: improve pharmaceutical governance; build capacity to manage malaria products while addressing the information needed for managing them; strengthen financing strategies and mechanisms to improve access to malaria medicines; and improve the quality of pharmaceutical services provided to malaria patients.

Areas supported by SIAPS include: training; quantification; strengthening supply chain systems, including logistics management information; community and malaria case management; rational use; and medication safety. SIAPS works to strengthen malaria pharmaceutical management at the national level in Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Guinea, Mali, and South Sudan. In addition, SIAPS provides regional support in Latin America.

This report briefly describes the major activities that SIAPS conducted at the global level and in each of the countries and region mentioned above between April and June 2015.

Read full story · Comments are closed

World Malaria Day 2015: Defeating Malaria Through Stronger Pharmaceutical Systems

Approximately 3.3 billion people— nearly half of the world’s population— live at risk of becoming infected with malaria. The World Health Organization (WHO) estimates that there are 198 million clinical malaria cases and nearly 600,000 deaths caused by malaria each year, with 78% of deaths occurring in children under five years of age. Though developed […]

Read full story · Comments { 0 }

Malaria Quarterly Updates July-September 2013

This report briefly describes the major activities that SIAPS carried out at the global level as well as in Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Guinea, Liberia, Mali, and South Sudan between July and September 2013.

Read full story · Comments are closed

Malaria Quarterly Updates January-March 2013

This report briefly describes the major activities that SIAPS carried out at the global level as well as in Angola, Burundi, the Democratic Republic of the Congo, Ethiopia, Guinea, Liberia, Mali, and South Sudan between January and March 2013.

Read full story · Comments are closed

Malaria Quarterly Updates April-June 2014

This report briefly describes the major SIAPS country activities in Angola, Burundi, the Democratic Republic of the Congo, Ethiopia, Guinea, Mali, and South Sudan as well regional activities for Latin America between April and June 2014.

 

Read full story · Comments are closed